Gemina Laboratories (XCNQ:GLAB) ROCE % : 0.00% (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gemina Laboratories's annualized ROCE % for the quarter that ended in Oct. 2023 was 0.00%.

Gemina Laboratories ROCE % Historical Data

The historical data trend for Gemina Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories ROCE % Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

ROCE %

-825.46

-1,110.49

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
ROCE %	Get a 7-Day Free Trial						-315.11	-1,138.37	-757.03	-624.33	-

Gemina Laboratories ROCE % Calculation

Gemina Laboratories's annualized ROCE % for the fiscal year that ended in Jan. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2023 )		(A: Jan. 2022 )		(A: Jan. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2023 )		(A: Jan. 2022 )		(A: Jan. 2023 )
	=	-5.98	/	( ( (1.42 - 0.47)	+	(1.875 - 1.748) )	/ 2 )
	=	-5.98	/	( (0.95	+	0.127)	/ 2 )
	=	-5.98	/	0.5385
	=	-1,110.49 %

Gemina Laboratories's ROCE % of for the quarter that ended in Oct. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Oct. 2023 )		(Q: Jul. 2023 )		(Q: Oct. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Oct. 2023 )		(Q: Jul. 2023 )		(Q: Oct. 2023 )
	=	-3.488	/	( ( (1.848 - 1.505)	+	(1.683 - 2.126) )	/ 2 )
	=	-3.488	/	( ( 0.343	+	-0.443 )	/ 2 )
	=	-3.488	/	-0.05
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Oct. 2023) EBIT data.

Gemina Laboratories (XCNQ:GLAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gemina Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GLABF:USA 8I7:Germany

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines